196 related articles for article (PubMed ID: 170968)
21. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
22. Calcium-dependent DNA damage and adenosine 3',5'-cyclic monophosphate-independent glycogen phosphorylase activation in an in vitro model of acetaminophen-induced liver injury.
Salas VM; Corcoran GB
Hepatology; 1997 Jun; 25(6):1432-8. PubMed ID: 9185764
[TBL] [Abstract][Full Text] [Related]
23. Calcium and cyclic nucleotide interaction in secretion of amylase from rat pancreas in vitro.
Singh M
J Physiol; 1979 Nov; 296():159-76. PubMed ID: 93637
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylase a activity as an indicator of neutrophil activation by chemotactic peptide.
Slonczewski JL; Wilde MW; Zigmond SH
J Cell Biol; 1985 Oct; 101(4):1191-7. PubMed ID: 2995402
[TBL] [Abstract][Full Text] [Related]
25. Ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) and the tyrphostin ST271 inhibit phospholipase C in human platelets by preventing Ca2+ entry.
Watson SP; Poole A; Asselin J
Mol Pharmacol; 1995 Apr; 47(4):823-30. PubMed ID: 7723744
[TBL] [Abstract][Full Text] [Related]
26. Intracellular calcium dependent activation of p72syk in platelets.
Wang X; Sada K; Yanagi S; Yang C; Rezaul K; Yamamura H
J Biochem; 1994 Oct; 116(4):858-61. PubMed ID: 7883762
[TBL] [Abstract][Full Text] [Related]
27. The control of glycogen metabolism in yeast. 2. A kinetic study of the two forms of glycogen synthase and of glycogen phosphorylase and an investigation of their interconversion in a cell-free extract.
François J; Hers HG
Eur J Biochem; 1988 Jun; 174(3):561-7. PubMed ID: 2839335
[TBL] [Abstract][Full Text] [Related]
28. Evidence that cyclic AMP may regulate Ca2+-mobilization and phospholipases in thrombin-stimulated human platelets.
Imai A; Hattori H; Takahashi M; Nozawa Y
Biochem Biophys Res Commun; 1983 Apr; 112(2):693-700. PubMed ID: 6303329
[TBL] [Abstract][Full Text] [Related]
29. Hormonal regulation of glycogen metabolism in human fetal liver. I. Normal development and effects of dibutyryl cyclic AMP, glucagon, and insulin in liver explants.
Schwartz AL; Raiha NC; Rall TW
Diabetes; 1975 Dec; 24(12):1101-12. PubMed ID: 172397
[TBL] [Abstract][Full Text] [Related]
30. Abnormal platelet glycogen metabolism in multiple myeloma patients.
Agam G; Gutman A; Djaldetti M
Clin Chim Acta; 1977 Sep; 79(2):437-45. PubMed ID: 408057
[TBL] [Abstract][Full Text] [Related]
31. Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.
Lederer B; Van Hoof F; Van den Berghe G; Hers H
Biochem J; 1975 Apr; 147(1):23-35. PubMed ID: 168880
[TBL] [Abstract][Full Text] [Related]
32. Platelet phosphorylase kinase activity and its regulation by the calcium-dependent regulatory protein, calmodulin.
Gergely P; Castle AG; Crawford N
Biochim Biophys Acta; 1980 Mar; 612(1):50-5. PubMed ID: 7362832
[TBL] [Abstract][Full Text] [Related]
33. Modulation of basal hepatic glycogenolysis by nitric oxide.
Borgs M; Bollen M; Keppens S; Yap SH; Stalmans W; Vanstapel F
Hepatology; 1996 Jun; 23(6):1564-71. PubMed ID: 8675178
[TBL] [Abstract][Full Text] [Related]
34. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets.
Hultin MB
Blood; 1985 Jul; 66(1):53-8. PubMed ID: 3924141
[TBL] [Abstract][Full Text] [Related]
35. The effect of cyclic AMP on glycogenolysis and glycolysis in human platelets.
Zieve PD; Schmukler M
Biochim Biophys Acta; 1971 Nov; 252(2):280-4. PubMed ID: 4332298
[No Abstract] [Full Text] [Related]
36. Inactivation and reactivation of liver phosphorylase b kinase.
Vandenheede JR; Keppens S; De Wulf H
Biochim Biophys Acta; 1977 Apr; 481(2):463-70. PubMed ID: 15609
[TBL] [Abstract][Full Text] [Related]
37. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry?
Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487
[TBL] [Abstract][Full Text] [Related]
38. Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite.
Bergans N; Stalmans W; Goldmann S; Vanstapel F
Diabetes; 2000 Sep; 49(9):1419-26. PubMed ID: 10969824
[TBL] [Abstract][Full Text] [Related]
39. Evidence that the platelet plasma membrane is impermeable to calcium and magnesium complexes of A23187. A23187-induced secretion is inhibited by MG2+ and Ca2+, and requires aggregation and active cyclooxygenase.
Holmsen H; Dangelmaier CA
J Biol Chem; 1981 Oct; 256(20):10449-52. PubMed ID: 6793580
[TBL] [Abstract][Full Text] [Related]
40. Ca(2+)-dependent activation of the 33-kDa protein kinase transmits thrombin receptor signals in human platelets.
Ido M; Kato S; Ogawa H; Hayashi K; Komada Y; Zhang XL; Sakurai M; Suzuki K
Thromb Haemost; 1996 Sep; 76(3):439-43. PubMed ID: 8883283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
